Loading...
Back to narrative

CELSIA: Profit Margins And Earnings Multiple Will Define Near-Term Performance

Update shared on 27 Nov 2025

Fair value Increased 8.21%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
41.9%
7D
0.3%

Analysts have raised their price target for CELSIA E.S.P. from $4,875 to $5,275, reflecting improved outlooks on revenue growth and profit margins, even with a higher discount rate.

Valuation Changes

  • Fair Value: Increased from COP 4,875 to COP 5,275, reflecting a higher analyst estimate for the company's worth.
  • Discount Rate: Increased from 15.71% to 16.93%, indicating a slightly less favorable risk profile.
  • Revenue Growth: The projected decline is less severe, changing from -13.89% to -4.12%.
  • Net Profit Margin: Improved from 6.68% to 7.24%, suggesting better profitability expectations.
  • Future P/E: Decreased from 25.87x to 21.72x, indicating a more attractive earnings valuation.

Have other thoughts on CELSIA E.S.P?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.